Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 216

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Daily or Intermittent Budesonide in Preschool Children with Recurrent Wheezing

Open access
Zeiger, Robert S., Mauger, David, Bacharier, Leonard B., Guilbert, Theresa W., Martinez, Fernando D., Lemanske, Robert F., Strunk, Robert C., Covar, Ronina, Szefler, Stanley J., Boehmer, Susan, Jackson, Daniel J., Sorkness, Christine A., Gern, James E., Kelly, H. William, Friedman, Noah J., Mellon, Michael H., Schatz, Michael, Morgan, Wayne J., Chinchilli, Vernon M., Raissy, Hengameh H., Bade, Elizabeth, Malka-Rais, Jonathan, Beigelman, Avraham, Taussig, Lynn M. · 2011 · New England Journal of Medicine

Abstract

BACKGROUND: Daily inhaled glucocorticoids are recommended for young children at risk for asthma exacerbations, as indicated by a positive value on the modified asthma predictive index (API) and an exacerbation in the preceding year, but concern remains about daily adherence and effects on growth. We compared daily therapy with intermittent therapy. METHODS: We studied 278 children between the ages of 12 and 53 months who had positive values on the modified API, recurrent wheezing episodes, and at least one exacerbation in the previous year but a low degree of impairment. Children were randomly assigned to receive a budesonide inhalation suspension for 1 year as either an intermittent high-dose regimen (1 mg twice daily for 7 days, starting early during a predefined respiratory tract illness) or a daily low-dose regimen (0.5 mg nightly) with corresponding placebos. The primary outcome was the frequency of exacerbations requiring oral glucocorticoid therapy. RESULTS: The daily regimen of budesonide did not differ significantly from the intermittent regimen with respect to the frequency of exacerbations, with a rate per patient-year for the daily regimen of 0.97 (95% confidence interval [CI], 0.76 to 1.22) versus a rate of 0.95 (95% CI, 0.75 to 1.20) for the intermittent regimen (relative rate in the intermittent-regimen group, 0.99; 95% CI, 0.71 to 1.35; P=0.60). There were also no significant between-group differences in several other measures of asthma severity, including the time to the first exacerbation, or adverse events. The mean exposure to budesonide was 104 mg less with the intermittent regimen than with the daily regimen. CONCLUSIONS: A daily low-dose regimen of budesonide was not superior to an intermittent high-dose regimen in reducing asthma exacerbations. Daily administration led to greater exposure to the drug at 1 year. (Funded by the National Heart, Lung, and Blood Institute and others; MIST ClinicalTrials.gov number, NCT00675584.).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa1104647

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 216

Metadata

Authors
Zeiger, R. S., Mauger, D., Bacharier, L. B., Guilbert, T. W., Martinez, F. D., Lemanske, R. F., Strunk, R. C., Covar, R., Szefler, S. J., Boehmer, S., Jackson, D. J., Sorkness, C. A., Gern, J. E., Kelly, H. W., Friedman, N. J., Mellon, M. H., Schatz, M., Morgan, W. J., Chinchilli, V. M., Raissy, H. H., Bade, E., Malka-Rais, J., Beigelman, A., & Taussig, L. M.
Venue
New England Journal of Medicine
Published
2011-11-24
Volume
365
Issue
21
Pages
1990-2001
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2124283091
Cited by
216
References
2
FWCI
15.02
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Daily or Intermittent Budesonide in Preschool Children with Recurrent Wheezing. https://app.cochat.ai/papers/10.1056/nejmoa1104647
The paper
Zeiger, R. S., Mauger, D., Bacharier, L. B., Guilbert, T. W., Martinez, F. D., Lemanske, R. F., Strunk, R. C., Covar, R., Szefler, S. J., Boehmer, S., Jackson, D. J., Sorkness, C. A., Gern, J. E., Kelly, H. W., Friedman, N. J., Mellon, M. H., Schatz, M., Morgan, W. J., Chinchilli, V. M., . . . Taussig, L. M. (2011). Daily or Intermittent Budesonide in Preschool Children with Recurrent Wheezing. New England Journal of Medicine. https://doi.org/10.1056/nejmoa1104647

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.